Regulatory UK medicines regulator grants marketing authorisation to Enflonsia for RSV prevention PharmaTimesClesrovimab is first monoclonal antibody offering a single fixed dose for infantsInfectious DiseaseRead full story pharminent April 27, 2026 (Last updated: April 27, 2026) PharmaTimes Clesrovimab is first monoclonal antibody offering a single fixed dose for infants Infectious Disease Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Sun Pharma to acquire Organon for $11.75bnNext: UK biotech could be bound for recovery, BIA report reveals Related Stories Regulatory Outlook Therapeutics Secures FDA Approval for LYTENAVA pharminent July 31, 2026 Regulatory Outlook finally claims FDA approval for AMD drug pharminent July 27, 2026 Regulatory Outlook Therapeutics wins FDA approval for Lytenava in wet AMD pharminent July 27, 2026
